| Hepatitis-C | Treatments
New advances in the treatment of Hepatitis C

Reduce treatment time without losing effectiveness

| Hepatitis-C | Treatments
Treatment of hepatitis C: important observations

Following correctly the prescribed treatment is essential for its effectiveness.

| News | Treatments
To what extent is Sovaldi effective against hepatitis C?

Miguel Ángel Oliver interviews in Cuatro News the international expert Vicente Carreño. Those affected by hepatitis C claim that the 35,000 most serious cases immediately receive the drug Sovaldi.

| Treatments
Keys to stop the development of hepatitis C medicines apart

Hepatitis C has become the real protagonist of Spanish health for a few months, as a result of the protests initiated by patients (with enclosures in hospitals included).

| Hepatitis-C | Treatments
Efficacy of Immunotherapy with TG4040 in Chronic Hepatitis

TG4040 is a modified Ankara vaccine virus that expresses the hepatitis C virus NS3, NS4 and NS5B proteins (therapeutic vaccine). The Foundation participated in a phase II clinical trial in patients with chronic hepatitis C.

| Treatments
Treatment of chronic hepatitis C with faldaprevir and deleobuvir

En agosto la revista New England Journal of Medicine publica un artículo sobre el tratamiento libre de interferón de la hepatitis crónica C con Faldaprevir (inhibidor de la proteasa del virus) y Deleobuvir (inhibidor de la polimerasa vírica).

About Us

The Foundation for the Study of Viral Hepatitis is a benchmark in the field of hepatology worldwide, with the best specialists in liver diseases and molecular biology. A clinic specialized in internal medicine, liver and digestive system in Madrid

© 2018 - 2024 FEHV Clinic. All rights reserved.  Privacy Policy.  Cookies Policy.  Legal Notice.